Fact CheckerSign in

NCT06455670Not yet recruiting

Effects of Chinese Medicine on Patients With Severe Acute Exacerbation of COPD

Effects of Chinese Medicine on Patients With Severe Acute Exacerbation of COPD:A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Trial

Source: ClinicalTrials.gov · Last updated 22 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of this study was to evaluate the effects of Chinese Medicine on patients with severe AECOPD, and to provide a basis for the establishment of integrated CM and Western medicine diagnosis and treatment scheme for patients with severe AECOPD.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
468 (estimated)
First submitted
28 May 2024
Start date
20 Oct 2024
Primary completion date
30 Apr 2027
Lead sponsor
Henan University of Traditional Chinese Medicine
Diseases
COPD
NCT number
NCT06455670

What you commit to

  • Study type: Interventional
  • Planned participants: 468
  • From 20 Oct 2024 to the primary completion date, 30 Apr 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participate in other drug clinical investigators within 1 month before enrollment.

Other illness

  • delirious, dementia, various mental patients and other people who cannot communicate normally.
  • Patients with severe cardiac insufficiency (NYHA grade IV), malignant arrhythmia and hemodynamic instability.
  • Patients with acute respiratory failure who require tracheal intubation or invasive mechanical ventilation.
  • Complicated with bronchiectasis, active tuberculosis, severe liver and kidney disease (severe liver disease refers to cirrhosis, portal hypertension and varicose vein bleeding, etc., serious kidney disease including dialysis, kidney transplantation, etc.), pneumonia, HIV infection or immunosuppressive state, advanced malignant tumor, etc.
  • Allergic to therapeutic drugs.

Other

  • Pregnant and lactating women.
  • long-term bedridden patients for various reasons.
  • Out-of-hospital treatment for more than 3 days.

Who the study is looking for

  • Patients with severe AECOPD.;
  • Age 40-80 years old;
  • Chinese medicine diagnosis consistent with external cold and internal drink syndrome, or phlegm-heat congestion of the lungs syndrome, or phlegm turbidity obstruction of the lungs syndrome;
  • Voluntarily accept the treatment and sign the informed consent form;

Age in the registry: 40 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.